title: The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
abstract: Organ exchange organizations such as Eurotransplant allocate organs on the basis of histocompatibility testing results. For this reason it is essential that all data reported by the affiliated laboratories are accurate and reliable. The Eurotransplant Reference Laboratory (ETRL) organizes proficiency testing schemes for the tissue-typing centers of the respective renal transplantation units participating in Eurotransplant. Each year, the ETRL sends out 8 peripheral blood samples of healthy blood donors for serological typing and crossmatching, 16 sera to screen for the presence and definition of HLA alloantibodies and 20 DNA samples for molecular typing to the 49 participating centers. The results are collected centrally and reported back to the participants in an open way. These exercises show that the quality of HLA typing, screening and crossmatching improved significantly over the years. In particular, the introduction of molecular typing for HLA-DR resulted in an increase of reliability. The clinical relevance of a reliable HLA typing was demonstrated in a selected group of transplants, the zero HLA-A,-B,-DR- mismatched group. After retyping the donors, 146 of the 3,458 matched transplants appeared to have a mismatch and those transplants had a significantly lower graft survival rate. A continuing problem, however, is the result of screening for panel reactive antibodies (PRA), where the percentage PRA reported for each serum varies significantly from center to center. The results indicate that the use of a PRA value for classification of patients and allocation of organs should be revisited.
authors.affiliation: Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: I I
authors.initials: II
authors.lastname: Doxiadis
authors.forename: M
authors.initials: M
authors.lastname: Witvliet
authors.forename: W
authors.initials: W
authors.lastname: Verduyn
authors.forename: P
authors.initials: P
authors.lastname: de Lange
authors.forename: J
authors.initials: J
authors.lastname: Tanke
authors.forename: G M
authors.initials: GM
authors.lastname: Schreuder
authors.forename: G G
authors.initials: GG
authors.lastname: Persijn
authors.forename: F H
authors.initials: FH
authors.lastname: Claas
mesh_terms: D002102:Cadaver; D006085:Graft Survival / Q000276:immunology; D006650:Histocompatibility Testing / Q000592:standards*; D006801:Humans; D007753:Laboratories / Q000592:standards*; D009426:Netherlands; D016377:Organ Transplantation; D011786:Quality Control; D014019:Tissue Donors; D014181:Transplantation Immunology